Clinical manifestations and emotional disorders in patients with new coronavirus infection (COVID-19)

Abstract

The Novel Coronavirus Disease (COVID-19) is characterized by a variety of clinical manifestations, including a predominant lesion of the respiratory system with the possible development of distress syndrome, the development of multiple organ failure. COVID-19 can cause depression, anxiety, and other emotional disorders, which may interfere with subsequent physical recovery.

The aim – clinical analysis of emotional disorders in patients with the Novel Coronavirus Infection (COVID-19).

Material and methods. A retrospective analysis of electronic medical records of 124 patients admitted to the infectious diseases department of Chelyabinsk City Clinical Hospital No. 8 in 2020–2021 was carried out. The methods of clinical and psychological research (including clinical conversation, observation and testing using the “Hospital Scale of Anxiety and Depression” HADS and the “Symptom Check List” SCL-90-R) were used to identify the features of the emotional states of patients with COVID-19. Statistical analysis was performed using the statistical package «Statistica 6.0». The Spearman rank correlation coefficient was used.

Results. Typical complaints upon admission to the hospital are fever, cough, general weakness, loss of smell and taste, runny nose. The majority of patients showed elevated levels of C-reactive protein and protein of the acute phase of inflammation – ferritin, an increase in the D-dimer by more than 2.5 times compared with the average standard values, a decrease in the value of the prothrombin index (mean value 88.7±6.4%) indicate coagulopathy as a manifestation of hyperinflammation that develops in COVID-19. More than half of patients (52.08±9.42%) experienced psychological distress of moderate and high severity: an increased level of distress was recorded in 42.78±9.33% of the examined patients, a high level of distress was found in 9.30±5.48% of patients. Direct correlations of varying degrees of strength between general somatic distress and indicators of anxiety, depression, psychopathological manifestations (obsessive-compulsiveness and interpersonal sensitivity) and mental distress were identified. Revealed negative emotional experiences in patients with COVID-19 can cause adverse effects on the course and prognosis of the disease, reduce adherence to treatment, negatively affect the social functioning and quality of life of patients.

Keywords:COVID-19; coronavirus infection; clinic; emotional disorders

Contribution. The concept and design of the study – Ratnikova L.I., Ragozinskaya V.G.; collection and processing of material – Ratnikova L.I., Ragozinskaya V.G.; statistical processing – Ragozinskaya V.G.; writing the text – Ratnikova L.I., Ragozinskaya V.G.; editing – Ratnikova L.I.

Funding. The study had no sponsor support.

Conflict of interest. The authors declare no conflict of interest.

For citation: Ratnikova L.I., Ragozinskaya V.G. Clinical manifestations and emotional disorders in patients with new coronavirus infection (COVID-19). Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2022; 11 (1): 19–24. DOI: https://doi.org/10.33029/2305-3496-2022-11-2-19-24

References

1. Carlos W.G., Dela Cruz S.C. Novel Wuhan (2019-nCoV) coronavirus. Am J Respir Crit Care Med. 2020; 201 (4): 7–8. DOI: https://doi.org/10.1164/rccm.2014P7

2. Maev I.V., Shpektor A.V., Vasil’eva E.Yu., Manchurov V.N., Andreev D.N. Novel coronavirus infection COVID-19: extrapulmonary manifestations. Terapevticheskiy arkhiv [Therapeutic Archive]. 2020; 92 (8): 4–11. DOI: https://doi.org/10.26442/00403660.2020.08.000767 (in Russian)

3. Paz C., Mascialino G., Adana-Díaz L. Anxiety and depression in patients with confirmed and suspected COVID-19 in Ecuador. Psychiatry Clin Neurosci. 2020; 74: 554–5. DOI: https://doi.org/10.1111/pcn.13106

4. Mazza M. G., De Lorenzo R., Conte C. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020; 89: 594–600. DOI: https://doi.org/10.1016/j.bbi.2020.07.037

5. Halpin S.J., McIvor C., Whyatt G. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2020; 93: 1013–22. DOI: https://doi.org/10.1002/jmv.26368

6. Bo H.X., Li W., Yang Y., Wang Y., et al. Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. Psychol Med. 2021; 51 (6): 1052–3. DOI: https://doi.org/10.1017/S0033291720000999

7. Zhang J., Lu H., Zeng H. The differential psychological distress of populations affected by the COVID-19 pandemic. Brain Behav Immun. 2020; 87: 49–50. DOI: https://doi.org/10.1016/j.bbi.2020.04.031

8. Rogers J.P, Chesney E., Oliver D. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020; 7: 611–27. DOI: https://doi.org/10.1016/S2215-0366(20)30203-0

9. Temporary guidelines. Prevention, diagnosis and treatment of New Coronavirus infection (COVID-19). Version 13 (10/14/2021). Moscow: Minzdrav Rossii, 2021: 236 p. URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/058/211/original/BMP-13.pdf (in Russian)

10. Litvinov A.S., Savin A.V., Kukhtina A.A., Sitovskaya D.A. Clinical and morphological parallels of lung and kidney damage in COVID-19. Nefrologiya [Nephrology]. 2020; 24 (5): 97–107. DOI: https://doi.org/10.36485/1561-6274-2020-24-5-97-107 (in Russian)

11. Zol’nikova O.Yu., Dzhakhaya N.L., Potskhverashvili N.D., Puzakov K.B., et al. Clinical traits of SARS-CoV-2 infection. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii [Russian Journal of Gastroenterology, Hepatology, Coloproctology]. 2020; 30 (6): 28–39. DOI: https://doi.org/10.22416/1382-4376-2020-30-6-28-39 (in Russian)

12. Akhmet’yanov M.A., Kicherova O.A., Reykhert L.I., Deeva M.V., et al. Neurological disorders associated with COVID-19 (literature review). Meditsinskaya nauka i obrazovaniye Urala [Medical Science and Education of the Urals]. 2020; (4): 140–4. DOI: https://doi.org/10.36361/1814-8999-2020-21-4-140-144 (in Russian)

13. Nasonov E.L. Coronavirus disease 2019 (COVID-19): a rheumatologist’s thoughts. Nauchno-prakticheskaya revmatologiya [Rheumatology Science and Practice]. 2020; 58 (2): 123–32. DOI: https://doi.org/10.14412/1995-4484-2020-123-132 (in Russian)

14. Shlyakhto E.V., Parmon E.R., Berngardt E.R., Zhabina E.S. Features of electrocardiographic changes in non-coronarogenic syndromes in patients with COVID-19. Rossiyskiy kardiologicheskiy zhurnal [Russian Journal of Cardiology]. 2020; 25 (7): 104–200. DOI: https://doi.org/10.15829/1560-4071-2020-4019 (in Russian)

15. Tarabrina N.V. Workshop on the psychology of post-traumatic stress. Saint Petersburg: Piter, 2001: 272 p. (in Russian)

16. Starshinova A.A., Kushnareva E.A., Malkova A.M., Dovgalyuk I.F., Kudlay D.A. New coronaviral infection: features of clinical course, capabilities of diagnostics, treatment and prevention in adults and children. Voprosy sovremennoy pediatrii [Problems of Modern Pediatrics]. 2020; 19 (2): 123–31. DOI: https://doi.org/https://doi.org/10.15690/vsp.v19i2.2105 (in Russian)

17. Mannanova I.V., Semenov V.T., Ponezheva Zh.B., Makashova V.V. Clinical and laboratory characteristics of COVID-19. Rossiyskiy meditsinskiy zhurnal [Russian Medical Journal]. 2021; (4): 22–5. (in Russian)

18. Salakhbekov I.S., Makoveeva O.V. Character of the clinical course of the new coronavirus infection in patients without the compromised premorbid background. Izvestiya Rossiyskoy Voenno-meditsinskoy akademii [Proceedings of the Russian Military Medical Academy]. 2021; 40 (S1-3): 281–5. (in Russian)

CHIEF EDITOR
CHIEF EDITOR
Yushchuk Nikolay Dmitrievich
Academician of the Russian Academy of Sciences, Professor, head of the Infectious Diseases and Epidemiology Department, President of the Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Board member of the National Scientific Infectiologists? Society.
Вскрытие
Medicine today

Уважаемые коллеги! Представляем оргкомитет 17-го Национального конгресса терапевтов (с международным участием) , который состоится 12-14 октября в МВЦ "Крокус Экспо" (павильон 3, Зал 20, г. Москва). · Президент Российского научного медицинского общества терапевтов,...

IV Съезд онкологов Московской области 7 октября 2022 года Активное развитие онкологической службы позволяет эффективно решать проблемы, возникающие на всех уровнях оказания помощи пациентам с онкозаболеваниями. Одним из успешных примеров такого взаимодействия является IV...

II Всероссийская конференция с международным участием "Воспаление глаза" 12 ноября 2022 года, Москва Воспалительные заболевания глаза - широко распространенная и многогранная проблема, с которой может столкнуться в своей практике любой специалист. Найти оптимальные алгоритмы...


Journals of «GEOTAR-Media»